Collectively, these results demonstrate that high activity of NRF2 can play a role in chemoresistance observed in many cancer types, and thus, the inhibition of NRF2-dependent antioxidative response seems an attractive approach to render cancer cells more susceptible to chemotherapeutic agents. This evidence concerns the gene NFE2L2 and cancer.